• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[服用抗酸剂后的粪便情况]

[Stool behavior following the administration of antacids].

作者信息

Kori-Lindner C

出版信息

Fortschr Med. 1984 Mar 22;102(11):318-22.

PMID:6714903
Abstract

The direct correlation between the dosage of magnesium in antacids and the appearance of partly massive diarrheas in ulcus-patients known from literature could be confirmed. The clinically relevant dosage of antacids of 420 mval NK/day, divided in six individual dosages, resulted in diarrheas from the second to fourth day in 32 percent of the test persons when antacid A with a high content of magnesium was administered. There was no hint for a constipating effect of Solugastril gel at these high dosages (= 12 individual doses). Indeed the application of an Al-Ca-antacid may result in a slight fecal impaction, however, at the same time also to an increase of stool frequency, which is similar to that obtained with antacid B having a lower content of magnesium. The antacid can be regarded as neutral concerning stool frequency and consistency in the majority of test persons. From all four tested antacids the triple-combination (Al, Mg, Ca), showed the least important deviations from the preceding norms concerning stool frequency and consistency. The triple-combination shows an absolutely neutral stool behaviour. Serum electrolytes remained in the normal range with the Al-Ca- and the Al-Mg-Ca-antacid; whereas after application of antacid. A with high magnesium content, important increases of magnesium could be observed after seven days already, which were also dealt with in the literature.

摘要

抗酸剂中镁的剂量与文献中已知的溃疡患者出现部分大量腹泻之间的直接相关性得到了证实。当给予镁含量高的抗酸剂A时,临床相关剂量为420mval NK/天,分为六个单次剂量,在32%的测试者中,从第二天到第四天会出现腹泻。在这些高剂量(=12个单次剂量)下,没有迹象表明Solugastril凝胶有便秘作用。事实上,应用铝钙抗酸剂可能会导致轻微的粪便嵌塞,但同时也会导致排便频率增加,这与镁含量较低的抗酸剂B相似。在大多数测试者中,抗酸剂在排便频率和粪便稠度方面可被视为中性。在所有四种测试的抗酸剂中,三联组合(铝、镁、钙)在排便频率和粪便稠度方面与先前标准的偏差最小。三联组合显示出绝对中性的排便行为。使用铝钙和铝镁钙抗酸剂时,血清电解质保持在正常范围内;而在使用高镁含量的抗酸剂A后,七天后就可以观察到镁的显著增加,这在文献中也有提及。

相似文献

1
[Stool behavior following the administration of antacids].[服用抗酸剂后的粪便情况]
Fortschr Med. 1984 Mar 22;102(11):318-22.
2
[Serum and urine electrolyte behavior under therapeutic dosage of a potent magnesium and aluminum hydroxide containing antacid].
Arzneimittelforschung. 1983;33(2):258-62.
3
Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.在一项针对健康志愿者的双盲、随机、安慰剂对照、三交叉研究中,瑞尼液与胃仙-U液对胃内pH值的影响。
Am J Gastroenterol. 1996 Jun;91(6):1173-80.
4
Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.含铝镁抗酸剂对加替沙星在健康志愿者体内生物利用度的影响。
Pharmacotherapy. 2007 Jul;27(7):963-9. doi: 10.1592/phco.27.7.963.
5
[Study on the interactions during storage of compounds of the antacid group. I. Interactions of the components in suspensions].[抗酸剂组化合物储存期间的相互作用研究。I. 混悬剂中各成分的相互作用]
Acta Pol Pharm. 1989;46(1):74-80.
6
Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.含氢氧化铝和氢氧化镁的抗酸混悬液的评估。
Am J Hosp Pharm. 1982 Nov;39(11):1925-30.
7
Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.两种抗酸制剂对胃内酸度影响的比较——一项双中心开放随机交叉安慰剂对照试验
Digestion. 2007;75(2-3):69-73. doi: 10.1159/000102627. Epub 2007 May 11.
8
Radiotelemetric comparison of two antacids using the Heidelberg capsule.使用海德堡胶囊对两种抗酸剂进行无线电遥测比较。
Arzneimittelforschung. 1984;34(10A):1378-80.
9
[Prostaglandin synthesis in stomach and duodenal mucosa of the human: effect of aspirin with and without antacid].
Z Gastroenterol. 1987 Aug;25 Suppl 3:162-5.
10
Antacid therapy--changes in mineral metabolism.
Scand J Gastroenterol Suppl. 1982;75:56-62.